research-icon-2016.png

Leading cancer research

Thanks to generous supporters Friends of ANCHOR have funded ground-breaking research to improve diagnosis and the treatment for cancer.

59 Pilot research projects 2010-2018

Supporting pilot research

Our long-term ambition is to attract and recruit a world-class oncology team to the region, in turn ensuring oncology research as a top priority for Aberdeen.

Since 2010, Friends of ANCHOR has funded 59 pilot research projects locally, in the fields of haematology and oncology. We are committed to continuing to fund these projects, with all research taking place locally at NHS Grampian, The University of Aberdeen and Robert Gordon University.

The charity awards funding up to £15,000 and below you can read more about which projects have received early seed funding this year.

We provide this level of support to help grow the foundations of our knowledge of cancer and haemophilia diseases, to produce initial data and results to attract large-scale research funding and to attract and retain top clinicians and researchers to the North-east, and ultimately, to benefit those who go through the ANCHOR Unit.

552k-pilot-research.png

Oncology research cancer types

 
Bowel
Brain
Breast
Gastric
Head/neck
Leukaemia
Lymphoma
Muscle
Ovarian
Pancreas
Prostate
Skin

Haematology research

 
Haemorrhage
Myeloproliferative Disease
Sickle Cell Anaemia
Thrombosis

Research targets

 
Underpinning biology
Treatment targets
Treatments
Imaging markers
Biological markers
Care outcomes
New technology
7 currently supported projects 2017-2018

Switching off the androgen receptor in advanced prostate cancer

Project
Disease Type: Prostate Cancer
Research Target: Treatment targets
Lead Researcher: Professor Iain J McEwan
Location: University of Aberdeen
Funding: £9,250
Background
Aims and research undertaken
Benefit to future ANCHOR Unit patients
Iain McEwan

Evaluating ability of new anti-cancer drug to inhibit growth and spreading of cancer cells

Project
Disease Type: Cancer
Research Target: Treatments
Lead Researcher: Dr Ian N Fleming
Location: University of Aberdeen
Funding: £9,700
Background
Aims and research undertaken
Benefit to future ANCHOR Unit patients
Dr Ian Fleming

Searching for new targets to treat colorectal cancer

Project
Disease Type: Bowel Cancer
Research Target: Treatment targets
Lead Researcher: Dr James Hislop
Location: University of Aberdeen
Funding: £9,538
Background
Aims and research undertaken
Benefit to future ANCHOR Unit patients
Dr James Hislop

What factors affect breast cancer neoadjuvant chemotherapy treatment?

Project
Disease Type: Breast Cancer
Research Target: Imaging markers
Lead Researcher: Dr Jiabao He
Location: University of Aberdeen
Funding: £9,744
Background
Aims and research undertaken
Benefit to future ANCHOR Unit patients
Dr jiabao he

Cancer cells exhibit an increased HMGB1 protein signal in early colon cancer development

Project
Disease Type: Bowel Cancer
Research Target: Underpinning biology
Lead Researcher: Dr Mairi McLean
Location: University of Aberdeen
Funding: £9,757
Background
Aims and research undertaken
Benefit to future ANCHOR Unit patients
Dr mairi mclean

New ways to help breakdown blood clots

Project
Disease Type: Thrombosis (Haematology)
Research Target: Underpinning biology
Lead Researcher: Dr Nicola J Mutch
Location: University of Aberdeen
Funding: £10,000
Background
Aims and research undertaken
Benefit to future ANCHOR Unit patients
Dr Nicola Mutch

Describing the microscopic and immunological features of head and neck cancer

Project
Disease Type: Head and Neck Cancer
Research Target: Underpinning biology
Lead Researcher: Dr Rasha Abu Eid
Location: University of Aberdeen
Funding: £9,719
Background
Aims and research undertaken
Benefit to future ANCHOR Unit patients
Dr Rasha Abu Eid.jpg
© Friends of ANCHOR | Registered Charity No. SCO25332 | 01224 859170 | foa@balmoral.co.uk